BX Swiss TOP 30 CHF
1.373,23
PKT
+13,12
PKT
+0,96
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 22.01.20 | UBS Outperform | Credit Suisse Group | |
| 22.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 22.01.20 | Swiss Re Outperform | Credit Suisse Group | |
| 22.01.20 | Holcim Neutral | UBS AG | |
| 22.01.20 | Roche buy | Jefferies & Company Inc. | |
| 22.01.20 | Swiss Re Hold | Jefferies & Company Inc. | |
| 22.01.20 | UBS overweight | JP Morgan Chase & Co. | |
| 22.01.20 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.20 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 21.01.20 | Roche buy | Merrill Lynch & Co., Inc. | |
| 21.01.20 | UBS Sector Perform | RBC Capital Markets | |
| 21.01.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 21.01.20 | UBS overweight | Morgan Stanley | |
| 21.01.20 | UBS Underweight | Barclays Capital | |
| 21.01.20 | UBS Hold | Deutsche Bank AG | |
| 21.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 21.01.20 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.01.20 | Swiss Re Sector Perform | RBC Capital Markets | |
| 20.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.01.20 | Holcim overweight | Barclays Capital | |
| 20.01.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 20.01.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 20.01.20 | UBS Equal weight | Barclays Capital | |
| 20.01.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 17.01.20 | UBS Outperform | Credit Suisse Group | |
| 17.01.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 17.01.20 | UBS Buy | UBS AG | |
| 17.01.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 16.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.01.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 16.01.20 | Novartis Underweight | Barclays Capital | |
| 16.01.20 | Roche overweight | Barclays Capital | |
| 16.01.20 | Roche Neutral | Credit Suisse Group | |
| 16.01.20 | Novartis Neutral | Credit Suisse Group | |
| 15.01.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 15.01.20 | UBS buy | Kepler Cheuvreux | |
| 15.01.20 | Nestlé Underperform | Credit Suisse Group | |
| 15.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 14.01.20 | Givaudan Neutral | JP Morgan Chase & Co. |